Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
18,214 total articles
iSpecimen Inc., a Nasdaq-listed online marketplace connecting scientists with biospecimens for medical research, announced the pricing of a $5 million public offering of common stock and pre-funded warrants at $1.30 per share. Proceeds will be used to repay liabilities, possibly acquire assets, invest in business and marketing activities, and for w…
Inuvo, Inc., a US-based AI advertising technology company, announced successful pilot results with a major health insurer using its IntentKey platform. The AI tool identified early consumer intent during the recent health insurance open enrollment period, leading to higher year-over-year enrollments and more targeted messaging based on consumer mot…
SRX Global Inc., an AI-driven investment platform, announces it will report its fiscal third quarter 2026 financial results and hold a conference call with a Q&A session on August 13, 2026. The company focuses on generating shareholder value through investments in high-conviction companies and strategic assets across multiple sectors using propriet…
Stran & Company, a leading outsourced marketing solutions provider specializing in promotional products and loyalty incentive programs, announced a conference call on August 12, 2026, to discuss its second quarter 2026 financial results and corporate developments. The call will feature insights into the company’s business progress and strategic ini…
Arteris, a semiconductor technology company specialized in network-on-chip interconnect IP, has appointed Saurabh Sinha as its new Chief Financial Officer effective September 8, 2026. Sinha replaces Nick Hawkins, who is retiring after seven years and will assist with the transition in an advisory capacity. Sinha brings extensive financial leadershi…
The Metals Company Inc. announced it will host a conference call on August 13, 2026, to discuss its second quarter 2026 financial results and recent corporate developments. The company is involved in developing critical metals from seafloor polymetallic nodules, focusing on supplying metals with lower environmental impact and advancing recycling ef…
Vistagen announced positive topline results from its Phase 2 repeat dose study evaluating fasedienol nasal spray for acute treatment of social anxiety disorder (SAD). The study showed favorable safety and tolerability, with numerical improvements over placebo on primary and secondary efficacy endpoints, particularly in patients with very severe SAD…
Propanc Biopharma announced highly encouraging preclinical data for its lead candidate PRP in treating pancreatic ductal adenocarcinoma, showing over 90% tumor growth inhibition, reduced metastasis, and more than 2.5-fold increase in median survival in animal models. The data supports PRP’s novel mechanism targeting cancer stem cells and tumor micr…
MiNK Therapeutics will report its Q2 2026 financial results and provide clinical updates on its off-the-shelf iNKT cell therapy agenT-797 targeting acute lung injury. The company will discuss new clinical data and the launch of a named-patient program, highlighting progress in treating pulmonary immune failure and other immune disorders.
AZIO AI Holdings, Inc. announced a significant sales agreement with Power Champion Investment Limited to supply up to 128 NVIDIA HGX B300 AI systems for deployment in U.S.-based AI infrastructure facilities. The deal potentially totals around $77 million in hardware value, reinforcing AZIO AI's growth in the AI infrastructure sector and expanding i…
Verisk's CargoNet business finds a 26% decline in cargo theft incidents in Q2 2026 compared with Q2 2025, but total financial losses more than doubled to $304.6 million driven by high-value metals and technology thefts. Declines in physical thefts and non-delivery fraud, especially in California and Texas, contrast with steady levels of compromise-…
CG Oncology reported its Q2 2026 financial results highlighting significant progress in clinical trials of its investigational oncolytic immunotherapy, cretostimogene, for non-muscle invasive bladder cancer. The company expects key Phase 3 trial topline data and regulatory submissions later in 2026. Strong cash reserves support operations through 2…
Freshworks Inc. announced that Freshservice, its AI-powered service operations platform, has achieved FedRAMP In-Process designation for Class C (Moderate) certification. This milestone moves Freshservice closer to full FedRAMP authorization, enabling broader adoption across U.S. federal agencies and other government entities requiring high securit…
Banzai International, Inc. announced its plan to change its corporate name to Parabolic Technologies, Inc. following shareholder approval, reflecting a strategic pivot towards building and investing in AI-based agentic applications. The company will reorganize into three business units focused on AI sales acceleration, enterprise software, and AI-p…
Rackspace Technology announced the appointment of Pranav Nambiar as Senior Vice President and General Manager, AI Infrastructure. Nambiar brings extensive experience from major tech firms to enhance Rackspace's AI infrastructure offerings, focusing on sovereign environments, compliance, and operational scale, positioning the company as a leader in …
Core AI Holdings, a Nasdaq-listed global AI technology firm, announced strong operational execution in the first half of 2026, achieving accelerated product milestones ahead of schedule and significant growth in user acquisition across its gaming portfolio. The company expanded its AI-driven analytics capabilities, improved internal reporting accur…
Harmony Biosciences Holdings, Inc., a pharmaceutical company focused on innovative therapies for rare neurological diseases, announced that its management team will participate in a fireside chat at the Piper Sandler Virtual CNS Symposium on August 13, 2026. The event will be webcast on the company's investor webpage.
VivoSim Labs, a Nasdaq-listed biopharma services provider specializing in 3D human tissue models, announced regaining compliance with Nasdaq Listing Rule 5550(b)(1) following a $5 million milestone payment from Eli Lilly, additional escrow funds, and a $4 million equity financing. With cash on hand exceeding $10 million and a significant increase i…
Belite Bio announced a webcast to discuss its second quarter 2026 financial results and business update, focusing on its clinical-stage drug development targeting degenerative retinal diseases. The company is advancing trials for its lead candidate tinlarebant, intended to treat Stargardt disease type 1 and geographic atrophy in age-related macular…
Ascendis Pharma announced positive data from its Phase 2 COACH trial combining TransCon CNP and TransCon hGH, showing sustained, unprecedented growth in children with achondroplasia through Week 78. Additionally, the pivotal ApproaCH trial demonstrated durable benefits from TransCon CNP monotherapy over two years. The company also reported signific…
Theriva Biologics has dosed the first patient in its VIRAGE2 Phase 2a trial, aiming to evaluate more frequent dosing of its oncolytic virus therapy, VCN-01, in combination with standard chemotherapy for metastatic pancreatic ductal adenocarcinoma (PDAC). Building upon encouraging Phase 2b data, this exploratory study seeks to refine dosing regimens…
ALX Oncology reported second quarter 2026 financial results, highlighted advancements in clinical trials for its oncology therapies evorpacept and ALX2004, reinforced its leadership team, and secured a new debt facility. The company remains on track for topline data from its Phase 2 breast cancer trial in mid-2027 and expects initial safety data fr…
Corbus Pharmaceuticals Holdings, Inc. reported Q2 2026 financial results and provided a corporate update highlighting FDA clearance to proceed with the registrational TEMPO-1 Phase 3 trial for CRB-701 in oropharyngeal cancer, and upcoming data from the CANYON-1 Phase 1b study of CRB-913 for obesity. The company also announced key senior leadership …
SHF Holdings, Inc. (Safe Harbor) announced that Canopy HR has selected Safe Harbor's Multiple Employer 401(k) Plan as the recommended retirement solution for its cannabis industry clients. Since its launch in April 2026, the plan has onboarded six new cannabis businesses, including a multistate operator, demonstrating strong early market adoption. …
Merlin, Inc. has successfully reached the Stage of Involvement 3 (SOI 3) milestone with the Civil Aviation Authority of New Zealand for key components of its autonomous flight system. This accomplishment advances Merlin's certification process, demonstrating the safety and reliability of their aviation-grade autonomous flight technology. The compan…
